Educational resources

This section includes resources developed by Guidelines, including algorithms, medicines appraisal cards, supplements, and videos. Items may contain pharmaceutical promotional information.

Videos

The holistic management of patients requiring anticoagulation

Commissioned by Bayer plc

This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021

Modern management of venous thromboembolism in primary care

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS − Pfizer Alliance and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View Eliquis (apixaban) prescribing and adverse event reporting information
432-GB-2100016
Date of preparation: February 2021

Non-alcoholic steatohepatitis: identification, management, and referral pathways

Commissioned by Intercept Pharma UK and Ireland Ltd

The content on this page is intended for UK healthcare professionals only.

Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes

Commissioned by Viatris

In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3287 December 2020

Assessment of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the assessment of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3288 December 2020

Management of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the management of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3289 December 2020

Management of common eye conditions: blepharitis

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) explains the symptoms and management of blepharitis.

Management of common eye conditions: conjunctivitis

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) describes the causes, symptoms, and treatment of conjunctivitis.

Management of common eye conditions: dry eye

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) covers the presentation, causes, and treatment of dry eye.

Management of common eye conditions: corneal and subtarsal foreign bodies

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the symptoms and treatment of foreign bodies in the eye.

Webinars

Modern management of stroke prevention in non-valvular atrial fibrillation

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

This promotional webinar has been funded by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance and organised in partnership with Guidelines.
Eliquis (apixaban) prescribing and adverse event reporting information.
432-GB-2100118 Date of preparation: March 2021

Promotional content

ClinOwl - A new resource for healthcare professionals

Promotional material from ClinOwl Ltd

A free resource, which aggregates and curates the latest clinical articles from leading medical journals in a single view. Keep up to date quickly and easily. You will be redirected to ClinOwl.com.

Medicines appraisal cards

NICE Technology Appraisal 664: Liraglutide for managing overweight and obesity

Commissioned by Novo Nordisk Limited

The production and printing of this Guidelines summary card has been commissioned by Novo Nordisk Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK21SX00044
January 2021

Supplements

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View Trajenta^® (linagliptin) prescribing and adverse event reporting information
PC-GB-103452 Date of preparation: January 2021

Prescribing hormone replacement therapy (HRT) in postmenopausal women: a focus on Oestrogel® (estradiol) and Utrogestan® 100 mg (micronised progesterone)

Commissioned by Besins Healthcare (UK) Ltd

This prescribing supplement has been commissioned and funded by Besins Healthcare (UK) Ltd and developed in partnership with Guidelines. Includes promotional information.
View prescribing and adverse event reporting information
OES/2021/001 February 2021
For healthcare professionals only.

The re-usable Respimat® Soft Mist inhaler

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View prescribing information
PC-GB-103141 November 2020

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines.
Date of preparation: January 2021

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.

Prescribing summary cards

DuoResp® Spiromax® (budesonide/formoterol)

Commissioned by Teva UK Limited

This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Click here for prescribing information and adverse event reporting.
DUOR-GB-00021
Date of preparation: August 2020

Working party guidelines and algorithms

Diabetes and frailty: guidance on the management of older adults with type 2 diabetes

By Strain Down Brown Puttanna and Sinclair

Information intended for UK healthcare professionals only. This summary was developed by Guidelines and Dr Strain, based on the guidance developed by Strain WD et al., with the support of a sponsorship from Novo Nordisk UK.

Managing obesity in primary care

By Development Group—Tahrani Parretti O’Kane Chowhan Ratcliffe and Le Brocq

This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.

Anticholinergics and cognitive impairment in the treatment of overactive bladder

Commissioned by Contura Ltd

This management algorithm has been commissioned and funded by Contura Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals.
View adverse event reporting and prescribing information

REG/2020/224 September 2020